Covid-19 Vaccine Supplies from India Have Reached at Least Six African Nations: Official

[ad_1]

Read More/Less


COVID vaccine supplies from India have landed in at least six African nations and millions of doses are committed for UN health workers and peacekeepers on a grant basis, a top official said on Monday. Addressing the ‘Namaskar Africa’ virtual event hosted by industry body Ficci, Rahul Chhabra — Secretary (Economic Relations) in the Ministry of External Affairs — also urged Indian firms to leverage the advantages presented by the Africa Continental Free Trade Area Agreement (AfCFTA) that came into effect from January 1 this year.

He said the agreement provides various opportunities to Indian companies. “I hope Ficci members are able to grab the enormity of the change that has come about in Africa and make the mostof it, be the first movers and take advantage of this Africa Continental Free Trade Agreement,” he said.

AfCFTA aims at establishing a free trade regime across the continent. Chhabra also said that vaccine supplies have already gone out and at least six African countries have received them, including Seychelles, Mauritius, Algeria, Morocco, Egypt and South Africa.

According to him, India is working with its partner nations and the vaccine supplies are beginning to roll out, adding that streamlining of processes and waiting for approvals from the partner countries led to hold up of a few days. “We were just streamlining the processes and waiting for approvals from our partner countries,” he said, adding that the government did not want a situation where after the vaccines land, countries do not have storage facilities, there is a lack of approvals and have not got their vaccination centres up and operational.



[ad_2]

READ FULL ARTICLE HERE

Formula One set to reject Bahrain vaccines offer | Racing News – Times of India

[ad_1]

Read More/Less


PARIS: Formula One is set to turn down an offer by Bahrain to vaccinate all teams and personnel against Covid-19 when they arrive for pre-season testing this month.
Following the postponement of the Australian Grand Prix, which was scheduled for March 21, the focus of the new season is firmly on Bahrain with testing due to run from March 12 to 14 with the opening Grand Prix of the 2021 season taking place there on March 28.
“The vast majority of participants will be present in Bahrain for a three-week period ahead of the race,” Bahraini organisers of the Grand Prix said in a statement on Sunday evening.
“This, in turn, allows a unique opportunity to provide additional protection for those who wish to take up the opportunity in the form of vaccination (Pfizer-BioNTech vaccine).”
Highlighting “one of the highest vaccination rates globally” with now “five different vaccines” available to the population, Bahrain said it was “extending the programme to major events in the kingdom on a voluntary basis where timescales allow”.
According to a source within Formula 1, the offer will be rejected.
Based in the United Kingdom, like the vast majority of teams, F1 intends to remain in line with the British vaccination schedule so that its employees are not seen to be benefitting from privilege.
More than 20 million people have already received a first dose of the coronavirus vaccine in the UK, which has recorded almost 123,000 deaths, the most of any country in Europe.
The decision to run Grands Prix in Bahrain has stirred controversy in the past on account of the kingdom’s human rights record.
In November 2020, 16 human rights groups wrote to Formula One accusing them of playing a “central role in ‘sportswashing’ the Bahraini government’s human rights abuses and “performing invaluable PR for Bahrain’s government and risk further normalising the violation of human rights in the country”.

[ad_2]

READ FULL ARTICLE HERE

Tokyo Asks China to Stop Anal Swab Covid Tests on Japanese Citizens

[ad_1]

Read More/Less


TOKYO: Tokyo has requested Beijing to stop taking anal swab tests for COVID-19 on Japanese citizens as the procedure causes psychological pain, a government spokesman said on Monday.

Chief Cabinet Secretary Katsunobu Kato said the government has not received a response that Beijing would change the testing procedure, so Japan would continue to ask China to alter the way of testing.

“Some Japanese reported to our embassy in China that they received anal swab tests, which caused a great psychologial pain,” Kato told a news conference.

It was not known how many Japanese citizens received such tests for the coronavirus, he said.

Some Chinese cities are using samples taken from the anus to detect potential COVID-19 infections as China steps up screening to make sure no potential carrier of the new coronavirus is missed.

China’s foreign ministry denied last month that U.S. diplomats in the country had been required to take anal swab tests for COVID-19, following media reports that some had complained about the procedure.



[ad_2]

READ FULL ARTICLE HERE

NZC Shifts Matches Against Australian Men, England Women to Wellington

[ad_1]

Read More/Less


NZC Shifts Matches Against Australian Men, England Women to Wellington

New Zealand’s upcoming T20 International against Australian men and their women’s national team fixture against England, slated to be held in Tauranga, were on Monday moved to Wellington due to logistical reasons. The double header — the Black Caps’ final T20I against Australia and the New Zealand women’s team’s T20 fixture against England on Sunday — will be held behind closed doors, New Zealand Cricket (NZC) said.

“The change has been forced on NZC because of logistical complications arising from the transfer of this Friday’s second double-header from Auckland to Wellington,” NZC said in a statement.

Last week, the NZC had shifted Friday’s double headers from the Eden Park to Wellington, after COVID-19 alert Level 3 restrictions were imposed in Auckland, which doesn’t allow any sports event to take place.

The rest of the country has been placed in Level 2 of the alert system which means that matches will have to take place behind closed doors.

“The current Alert Level 2 protocols in Wellington mean all three double-headers on Wednesday, Friday and Sunday, will be played behind closed doors.”

“Tickets purchased for matches affected by Alert Level restrictions will automatically receive full refunds to the card or bank account number from which they were paid,” NZC added.





[ad_2]

READ FULL ARTICLE HERE

US Children Could Receive Vaccine By Year-end, Says Fauci

[ad_1]

Read More/Less


The United States could start vaccinating older children against Covid-19 by the fall and younger ones by year-end or early 2022, the White House’s top pandemic advisor Anthony Fauci said Sunday.

The mass vaccination of school-age children will allow millions of children to return sooner to in-person learning and ease the burden on millions of parents now caring for their offspring at home.

School reopenings, an intensely debated matter, have varied sharply across the country, with some private and religious schools opening before public schools and teachers in some areas protesting any early return.

But the decision Saturday by the US Food and Drug Administration to grant emergency use authorization to a new single-dose vaccine from Johnson & Johnson has boosted the prospects for earlier reopenings.

“We now have three really efficacious vaccines,” Fauci said on ABC’s “This Week.”

For now, none of the three authorized vaccines in the US (also including Pfizer/BioNTech and Moderna) has been cleared for children under 16, but trials on children are under way.

Children in high school — roughly ages 14-18 in the United States — should be able to get the vaccine “sometime this fall,” Fauci told NBC’s “Meet the Press.”

“I’m not sure it’ll exactly be on the first day that school opens, but pretty close to that,” he added.

Data are still being compiled on the vaccines’ safety and efficacy for children in elementary or middle school — usually aged between five and 13 years old in the United States — so “realistically” they may not be able to receive the vaccine until late 2021 or early 2022, Fauci said.

Speaking Sunday evening at the Conservative Political Action Conference in Orlando, Florida, former president Donald Trump urged the new administration to reopen schools.

“On behalf of the moms, dads and children of America, I call on Joe Biden to get the schools open and get them open now,” said Trump.

Although the federal government issues guidelines on public health, it largely up to locally elected school boards when to reopen classrooms, not the president.

Children and adolescents are less commonly infected with the virus than adults, and in-person learning in schools has not been associated with substantial community transmission.

With Covid-19 still ravaging the US, the worst-hit country in the world, roughly half of students are currently attending school in person, the New York Times reported recently.

Earlier this month the US Centers for Disease Control and Prevention (CDC) issued new guidelines urging schools to reopen safely and as soon as possible.

The strategy emphasizes universal masking, hand-washing and disinfection, as well as contact tracing.

he CDC recommends vaccination for teachers and staff as soon as supply is available, and calls for different approaches depending on the level of community transmission in a given area.



[ad_2]

READ FULL ARTICLE HERE

Registration for Next Phase of Coronavirus Vaccination on Co-WIN 2.0 Begins March 1: All You Need to Know

[ad_1]

Read More/Less


The next phase of the COVID-19 vaccination drive for people above 60 years and those aged 45 and above with comorbidities will begin from March 1 and registration on the Co-WIN2.0 portal will open at 9 am on Monday. Citizens will be able to register and book an appointment for vaccination, anytime and anywhere, using the Co-WIN 2.0 portal or through other IT applications such as Arogya Setu.

Here is everything you need to know:

When Will Registration Open? Registration will open at 9 am on March 1 at www.cowin.gov.in, the ministry said. All citizens that are aged, or will attain the age of 60 or more as on January 1, 2022 are eligible to register, in addition to all such citizens that are aged, or will attain the age of45 to 59 years as on January 1, 2022, and have any of the specified 20 comorbidities.

◕ This information was shared during the orientation workshop organised by the Union Health Ministry and the National Health Authority (NHA) for the 10,000 private hospitals under Ayushman Bharat PMJAY, more than 600 hospitals empanelled under CGHS and other private hospitals empanelled under State Government’s Health Insurance Schemes, on Co-WIN2.0. The modalities of the new features integrated in the Co-WIN2.0 digital platform were explained to them.

◕ The private empanelled COVID-19 Vaccination Centres (CVCs) were also trained on various aspects of the process of vaccination and management of adverse events following immunization (AEFI) through video conference with the support of the National Health Authority (NHA). “There will be only one live appointment for a beneficiary at any point of time for each dose.

When Will Appointments Close? “Appointments for any date for a COVID Vaccination Center will be closed at 3 pm on that day for which the slots were opened,” the ministry said. For example, for March 1 the slots will be open from 9 am till 3 pm and the appointments can be booked anytime before that, subject to availability.

◕ However, on March 1, an appointment can also be booked for any future date for which vaccination slots are available. A slot for the second dose will also be booked at the same COVID Vaccination Centre on 29th day of the date of appointment of the 1st dose. If a beneficiary cancels a first dose appointment, then appointment of both doses will be cancelled, the ministry said.

On-site Registration: According to the ministry, there will be a facility of on-site registration so that eligible beneficiaries can walk into identified vaccination centres, get themselves registered and inoculated. The eligible persons will be able to register at the Co-WIN2.0 portal through their mobile number, through a step by step process.

◕ With one mobile number, a person can register as many as four beneficiaries. However, all those registered on one mobile number will have nothing in common except the mobile number, the ministry said. The photo ID card number for each such beneficiary must be different. Either of the following photo identity documents can be used by citizens for availing of online registration — Aadhaar Card/Letter, Electoral Photo Identity Card (EPIC), passport, driving license,PAN Card,NPR Smart Card or Pension Document with photograph.

◕ A user guide for the citizen registration and appointment for vaccination has also been uploaded on the websites of the Union Ministry of Health and National Health Authority (NHA). It was also explained that the central government shall procure all the vaccines and supply them free of cost to the states and UTs who in turn will disburse them further to the government and private COVID Vaccination Centres (CVCs), the ministry said.

◕ It was re-iterated that all vaccines provided to beneficiaries at the government health facilities will be entirely free of cost, while private facilities cannot charge the beneficiary a sum above Rs 250 per person per dose (Rs 150 for vaccines and Rs 100 as operational charges). Private hospitals will have to remit the cost of vaccine doses allotted to them in a designated account of National Health Authority (NHA). Payment gateway for the same is being enabled by the NHA on their website, the ministry said.

◕ Government of India has supplied two COVID-19 vaccines, Covishield and Covaxin, free of cost to the states and UTs to vaccinate healthcare workers (HCWs) and frontline workers (FLWs) and they will also be able to cover the next priority group i.e. 60 years plus age group and the age group of 45 to 59 years suffering from pre-specified co-morbidities. The states have been requested to operationalise the linkages between the CVCs (both government and private empanelled facilities) with the nearest cold chain points for ensuring smooth vaccine delivery to (CVCs).

Co-morbid Conditions Specified: The ministry specified 20co-morbidities within the 45-59 years age group including heart failure with hospital admission in past one year, moderate or severe valvular heart disease, coronary artery disease, CT/ MRI documented stroke, diabetes (>10 years or with complications) and hypertension on treatment, end-stage kidney disease on haemodialysis,diagnosis of any solid cancer on or after 2000 or currently on any cancer therapy for which one will have to submit a medical certificate. The ministry has shared the format of the simplified one page certificate to be signed by any registered medical practitioner. The certificate can either be uploaded on Co-WIN2.0 by the beneficiary while self registering or a hard copy can be carried by the beneficiary to the CVC, the ministry said.

(With inputs from PTI)



[ad_2]

READ FULL ARTICLE HERE

China Rolls Out Single-jab Covid Vaccine Against Johnson and Johnson’s Shot

[ad_1]

Read More/Less


China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson’s one-jab shot cleared by the US drug regulator on Sunday. China’s first Ad5-nCoV COVID-19 vaccine was rolled out on Friday, the state-run Global Times reported on Sunday.

Phase-I clinical trials of the vaccine started on March 16, last year, making it the world’s first COVID-19 candidate vaccine that entered clinical trials, it said. It is the only single-dose COVID-19 vaccine that has been given conditional approval to be rolled out in China, the report quoted last Friday’s story by the state broadcaster China Central Television (CCTV).

People can get desirable protective effect after 14 days of inoculation. The protective effect can last at least six months after a single-dose inoculation and it can increase immune response by 10 to 20 times if the second dose is taken half a year after the first one, the report said.

With this, China’s medical products regulator has approved five coronavirus vaccines which include Sinovac, Sinopharm, CanSinoBio and another by Wuhan Institute of Biological Products. One of the developers of the Ad5-nCoV vaccine said that the annual production capacity can reach 500 million doses, which means 500 million people can be vaccinated in a year.

Phase-I clinical trials of the vaccine started on March 16, 2020, making it the world’s first COVID-19 candidate vaccine that entered clinical trials, the Global Times report said. Though China has been supplying its vaccines to different countries, none of them have been approved by the World Health Organisation (WHO).

The Ad5-nCoV vaccine is a recombinant adenovirus vector vaccine jointly developed by CanSino Biologics and researchers from the Institute of Military Medicine under the Academy of Military Sciences led by Chen Wei, who is an infectious disease expert and a researcher at the Institute of Military Medicine under the Academy of Military Sciences. “We have data for six months so far to prove the vaccine’s efficacy. People don’t need to take another dose within the first six months after their first inoculation. What if the epidemic is not over after six months? We have also developed the vaccine so that its effect is strengthened even after six months,” Chen said.

The US Food and Drug Administration on Saturday approved Johnson and Johnson’s COVID-19 vaccine, the third jab to be authorised to fight the pandemic that has claimed over half a million lives in the country. The vaccine is set to be a cost-effective alternative to the Pfizer and Moderna vaccines, and can be stored in a refrigerator instead of a freezer.

Trials found it prevented serious illness but was 66 per cent effective overall when moderate cases were included. The vaccine is made by the Belgian firm Janssen. China has been stepping up coronavirus vaccine production as it looks to vaccinate its 1.4 billion population and boost its vaccine diplomacy to make strategic gains.

Last Friday, China welcomed India supplying more COVID-19 vaccines to a number of countries, playing down reports that New Delhi has beaten Beijing in its vaccine diplomacy around the world. Responding to a question on a report that India has beaten China at its own game of vaccine diplomacy, Chinese Foreign Ministry spokesman Wang Wenbin during a media briefing said, We welcome that and hope to see more countries taking actions to provide vaccines to the world, especially developing countries, to help with the global response.

“China has been overcoming domestic difficulties to provide vaccines to other countries in concrete measure, he said, flagging China’s own vaccine requirement to inoculate its 1.4 billion population. He reiterated that China has been providing vaccines to 53 countries and exporting vaccines to 27 countries, amid reports that many of those countries are yet to receive Chinese vaccines or the promised quantities.



[ad_2]

READ FULL ARTICLE HERE

Coronavirus | Is India witnessing the beginning of the second wave?

[ad_1]

Read More/Less


While there were no large surges even during the festival season, ICMR’s third serosurvey found only 21.5% of India has been exposed to the virus

Six months after India witnessed a peak, a spike in daily fresh COVID-19 cases is seen in a handful of States, particularly in Maharashtra. From 10.9 million cases across India as on February 17, the cases shot up to 11 million on February 26, with daily cases staying above 13,000 from February 18 onwards and even almost touching 17,000 on February 24.

From below 5%, the test positivity rate has suddenly shot up in Maharashtra – the seven-day average test positivity rate in the State as on February 26 was 9.5%; the national figure stands at 1.9%. Does the sharp rise in numbers suggest the beginning of a second wave in India?

“No, the increase in daily cases is only a spike. It cannot be called as the beginning of a second wave, not even in Maharashtra,” says Dr. Giridhara Babu, Epidemiologist at the Public Health Foundation of India, Bengaluru and a member of the Karnataka COVID-19 Technical Advisory Committee. “There’s no strict definition for what a wave is; usually, epidemiologists refer to the second wave as a resurgence of infection in an area where the transmission had decreased to below the outbreak potential but is now continually increasing over a certain period.”

Dr. Babu adds that the prerequisites for defining the second wave are that the first wave should have been contained — the reproduction number or R0 is below 1.5 and low rate of infection has been sustained for at least one month.

Sharp criterion

The cumulative test positivity rate below 5% is generally used as a criterion to decide the end of a wave. Any increase in the cumulative test positivity rate beyond 5% and cases show a steadily increasing trend for over two-three continuous weeks are used to define the beginning of a wave.

The Karnataka COVID-19 task force also considered other criteria to define the beginning of a new wave – the seven-day average growth rate should be in excess of normal expectancy and where the test positivity rate doubles in a week despite there being no changes in the testing pattern, and hospitalisations double in the corresponding seven consecutive days. Also, the cases should be increasing steadily after crossing the basic reproduction rate (R0) more than 1.5. “Any of the above conditions that shows a steadily increasing trend for over two-three weeks is to be used to define the beginning of a new wave,” he says.

Too early

Referring to sudden spurt in daily cases in Maharashtra, he says it is a bit too early to call it as a second wave. “Yes, the number of cases starting to recede around mid-January, but there has been a spike in new cases in the last one week. We need to wait and see if it is sustained over the next one week at least. If there is sustained increase in cases along with either a doubling in hospitalisation or test positivity rate in a week then we can call it a second wave, at least in Maharashtra,” Dr. Babu explains.

Since millions have been infected by the first wave in India, and there have been no large surges in cases even during the festival season, winter and large gatherings, will India ever witness a second wave? “With the currently prevailing strains, I do not think that India, as a nation, will have a second wave bigger than the first wave. If anything, we will have second waves regionally in States, which may occur over a period, depending on compliance to COVID-19 appropriate behaviour, testing levels and population movement. For instance, Delhi witnessed not one but three waves. But we may not see a sudden spurt in cases in the entire country all at once,” he adds.

Third serosurvey

The third serosurvey of ICMR found that only 21.5% of India (around 225 million people) has been exposed to the virus — and hence, a large population is still vulnerable to infection. Dr. Babu is not entirely convinced with the results of the third serosurvey. “There is a lot of uncertainty looming around how long the IgG antibodies can be detected. The evidence suggests that IgG estimation underestimates the overall level of protection in the community. This is corroborated by the higher level of antibodies seen in the serosurveys done in many metros, such as Mumbai and Delhi,” he says.

“My own personal assessment is that we have had a greater number of infections in urban areas in the first wave. The threshold for population immunity might have been achieved in the densest settings, responsible for the greater number of cases in the first wave,” Dr. Babu adds.

New variant

But all these assumptions would prove wrong if a new variant that shows greater transmissibility either arises in India or those circulating in other countries spreads here. Dr. Babu says: “Newer variants, especially those capable of immune escape, can change everything we know, and this is the only way to have a second wave more devastating than the first wave. As of now, we have not seen such trends affecting India.”

This story is available exclusively to The Hindu subscribers only.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Xbox Series S Console Sold Out on Flipkart But You Can Still Try Your Luck on Amazon India

[ad_1]

Read More/Less


The latest Xbox Series X and Series S consoles were launched in India last year, but many fans are disappointed with their short supplies for months. While the availability details about the premium Xbox Series X remain unknown, the Xbox Series S has been briefly available on Flipkart and Amazon. However, it now appears that the stock on Flipkart is now over, and in contrast, Amazon will replenish its stock on March 9 – though customers can book their device from now. Both devices that debuted in India on November 10 compete against Sony’s latest PlayStation 5 console that too is witnessing a shortage in supply owing to the COVID-19 pandemic.

Customers can purchase the Xbox Series S console at Rs 34,990 for the single white colour option. You can also get the console with a single unit of the Xbox Wireless Controller for Rs 5,390, which brings the total amount to Rs 40,380. Additionally, Amazon is offering deals such as no-cost EMI payment mode and 5 percent cashback with HSBC Cashback card. Customers purchasing the console via Amazon Pay Later will Rs 100. On the other hand, Flipkart states that the Xbox Series S console will be available in India starting March 11, though it does not have the pre-book option that was available last week and also appears to be ‘Sold Out.’ Customers can select the ‘notify me’ option to get the latest updates from the Walmart-backed e-commerce platform.

To recall, there is no disk drive on the Xbox Series S so the games will have to be downloaded to its 512GB PCie Gen 4 NVME SSD. The console runs on a custom 8-core AMD Zen 2 CPU and custom AMD RDNA 2 GPU. It can play games at 1440p resolution at 60fps.

ALSO READ: Microsoft Admits Xbox Series X Supply Shortages Will Continue Till At Least June 2021

Earlier this month, Microsoft said that its flagship Xbox Series X console’s supply would continue to remain short until June 2021, months after warning about its short supply until April. The announcement had come from Microsoft’s head of investor relations, Mike Spencer in an interview with The New York Times. The Xbox’ supply chain is hindered by several factors including a shortage in supply of AMD chips – the Zen 2-based CPU and RDNA 2-based GPU – that feature on the Xbox Series X and Xbox Series S consoles.



[ad_2]

READ FULL ARTICLE HERE

Longest Hours, Least Wages, No Leisure: ILO Report Reveals India’s Non-Existent Work-Life Balance

[ad_1]

Read More/Less


According to a report by International Labour Organization (ILO), Indians are among the most overworked workers globally while earning the lowest minimum statutory wage in the Asia-Pacific region, barring Bangladesh.

ILO’s Global Wage Report 2020-21: Wages and Minimum Wages in the Time of COVID-19 states that India ranks fifth in the world among countries with long working hours, often stretching up to 48 hours a week, if not more. Only Gambia, Mongolia, Maldives and Qatar, where a quarter of the population is Indian, have average working hours longer than in India.

The report further observes that the minimum statutory wage of an Indian worker is the lowest in the world, except for some sub-Saharan African countries. Also, Indians spend less than one-tenth of time in a day for leisure, and especially women get far less time than men for leisure. It has also been estimated that self-employed and even salaried men and women spend more than six days in a week on activities relating to work.

Among Indians, it is the well-paid employees – both salaried and self-employed – in urban areas who work longer than those in the rural parts of the country. Casual workers across the country work for almost the same number of hours.

In rural India, while self-employed men work 48 hours, women spend 37 hours working in a week. In the case of regular wage and salaried employees, rural men work for 52 hours a week, while women work for 44 hours. As for casual labour, rural men work for 45 hours per week, and women spend 39 hours working.

In urban areas, self-employed men work 55 hours per week, while women work 39 hours. Salaried employees and regular wage earning men spend 53 hours a week working, while women work for 46 hours. In case of casual labour, urban men spend 45 hours a week working, while women work for 38 hours.

The estimates are deduced from 2019 assessments undertaken by national agencies, whilst data for some nations pertains to previous years.

While the above estimates include time spent on working, short breaks, lunch breaks, time spent travelling between different work locations as part of work, they do not, however, account for time spent commuting to and fro from work and longer meal breaks. Since the estimates are based on a household survey, the estimates include both formal and informal sector labour.



[ad_2]

READ FULL ARTICLE HERE

1 9 10 11 12 13